Demonising Justin Gatlin
13th September 2015
• The BMC Racing Team has terminated its contract with Samuel Sánchez Gonzalez, after analysis of the Spanish cyclist’s B sample confirmed the presence of GHRP-2. The International Cycling Union (UCI) informed the team that Gonzalez had failed a 9 August out of competition test. Growth Hormone Releasing Peptides (GHRPs) feature as ‘Peptide Hormones, Growth Factors, Related Substances and Mimetics’ under Section S2 of the World Anti-Doping Agency’s (WADA) Prohibited List.
• The Latin American football confederation (CONMEBOL) has issued seven month bans to Lucas Martinez Quarta and Camilo Mayada, reports Chinese news agency Xinhua. The two River Plate players reported adverse analytical findings (AAFs) for hydrochlorothiazide during June, which the Brazilian club blamed on contaminated supplements.
• The Amateur Swimming Association of Malaysia (ASUM) has confirmed that a diver tested positive for sibutramine at the recent South East Asia (SEA) Games in Kuala Lumpur, reports The Star. The athlete concerned has reportedly requested for their B sample to be tested.
• The Italian national anti-doping organisation (NADO Italia) has provisionally suspended four athletes following positive doping tests. Cyclist Raimondas Rumsas was provisionally suspended after returning an adverse analytical finding (AAF) for GHRP-6; as was cyclist Daniele Mariani following an AAF for a metabolite of clostebol; as was amateur athlete Pasquale Semeraro following AAFs for metabolites of higenamine, ephedrine and oxilofrine; as was 42 year old athlete Valeria Cirielli following an AAF for clenbuterol.
• Andy Brown, editor of The Sports Integrity Initiative, will be attending ‘Priorities for integrity and duty of care in sport – progress, policy options and the UK’s global contribution’, a Westminster Media Forum event in London tomorrow. Speakers include the UK government’s Department for Culture, Media and Sport (DCMS), UK Sport and UK Anti-Doping (UKAD). Live coverage will feature on The Sports Integrity Initiative’s Twitter account. The full programme for the day is available here.
• The Court of Arbitration for Sport (CAS) has approved a settlement agreement between the international equestrian federation (FEI) and US athlete Paige Johnson in what it terms a ‘substance reclassification’ case. In April, the FEI announced that Johnson’s horse, Luke Skywalker 46, had tested positive for pramoxine, a prohibited substance. Since then, pramoxine has been reclassified as a controlled medication, and the CAS approved a settlement agreement involving the reduction of Johnson’s ban from one year to three months, meaning she is now eligible to compete.
The jury’s verdict in the FIFAGate trial in New York is more nuanced and potentially...
Today, the World Anti-Doping Agency’s (WADA’s) Intelligence and Investigations (I&I) Team — led by Gunter...